Target Populations and Treatment Cost for Bempedoic Acid and PCSK9 Inhibitors: A Simulation Study in a Contemporary CAD Cohort
Christopher Blaum, Fabian J. Brunner, Alina Goßling, Friederike Kröger, Benjamin Bay, Thiess Lorenz, Annika Graef, Tanja Zeller, Renate B. Schnabel, Peter Clemmensen, Dirk Westermann, Stefan Blankenberg, Moritz Seiffert, Christoph Waldeyer
Topics & Concepts
PCSK9MedicineEzetimibeStatinCoronary artery diseaseCohortDyslipidemiaInternal medicineFamilial hypercholesterolemiaKexinProprotein convertaseGastroenterologyUrologyPharmacologyCholesterolLDL receptorDiseaseLipoproteinLipoproteins and Cardiovascular HealthHIV-related health complications and treatmentsCoronary Interventions and Diagnostics